Physician profile
Carlos Omar Rodriguez
NPI 1467533612
$5,573.81
in general payments reported to CMS, 2019-2025
15 companies · $1,016 in 2025
The $1,016 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,387 · 2020: $360 · 2021: $696 · 2022: $641 · 2023: $553 · 2024: $921 · 2025: $1,016.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,481 · Education: $9.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,481.07 |
| Education | $9.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,099.75 | 2019-2025 | Corevalve Evolut R, Linq II, Symplicity G3 |
| Abbott Laboratories | $1,166.02 | 2019-2025 | Aveir, Gallant, Jot Dx |
| Boston Scientific Corporation | $629.87 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor, General - Tachy |
| Astrazeneca Pharmaceuticals LP | $506.87 | 2019-2025 | Farxiga, Lokelma, Brilinta |
| Amgen INC. | $216.75 | 2019-2022 | |
| Actelion Pharmaceuticals US, INC. | $160.56 | 2021-2024 | Opsumit, Uptravi |
| Janssen Pharmaceuticals, INC | $135.00 | 2019-2023 | Xarelto, Invokana |
| Impulse Dynamics (USA) INC. | $121.90 | 2023 | Optimizer |
| Pfizer Pharmaceuticals LLC | $120.42 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $112.55 | 2019 | |
| Pbg Puerto Rico LLC | $98.50 | 2019-2023 | |
| Medtronic Vascular, INC. | $81.56 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $56.58 | 2022-2024 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $42.71 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $24.77 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carlos Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.